Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Transcode Therapeutics, Inc.

NASDAQ: RNAZ · Life Sciences · 4 alerts · CIK 1829635

Share price
$1.35Close, Nov 16
Market cap
$23.4M
Shares outstanding
17.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Transcode Therapeutics, Inc. filings on SEC EDGAR ↗

9:09 AM ET 8-K
Leadership Change

Transcode Therapeutics Leadership Change

Thomas A. Fitzgerald resigned as CFO and Director of TransCode Therapeutics effective September 9, 2026. The company entered into a separation agreement providing for up to $1.25 million in severance payments, accelerated vesting of existing equity, and a new grant of 185,000 stock options. A portion of the cash severance and option vesting is contingent on the company achieving specific funding thresholds of $5 million and $10 million.

Counterparty
Thomas A. Fitzgerald
Term
12 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.